Concepts (90)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Physical Examination | 2 | 2019 | 166 | 1.150 |
Why?
|
| Dyspnea | 2 | 2024 | 160 | 0.940 |
Why?
|
| Atrial Pressure | 1 | 2023 | 6 | 0.810 |
Why?
|
| Strongyloides stercoralis | 1 | 2022 | 23 | 0.780 |
Why?
|
| Strongyloidiasis | 1 | 2022 | 44 | 0.780 |
Why?
|
| Accidental Falls | 1 | 2024 | 120 | 0.770 |
Why?
|
| Patient Positioning | 1 | 2023 | 57 | 0.770 |
Why?
|
| Thrombophlebitis | 1 | 2020 | 21 | 0.690 |
Why?
|
| Klebsiella Infections | 1 | 2021 | 62 | 0.690 |
Why?
|
| Urinary Retention | 1 | 2020 | 19 | 0.690 |
Why?
|
| Bacteriological Techniques | 1 | 2021 | 90 | 0.690 |
Why?
|
| Cyanosis | 1 | 2020 | 43 | 0.680 |
Why?
|
| Webcasts as Topic | 1 | 2020 | 7 | 0.670 |
Why?
|
| Narration | 1 | 2020 | 33 | 0.660 |
Why?
|
| Thinking | 1 | 2020 | 35 | 0.650 |
Why?
|
| Fever | 1 | 2022 | 312 | 0.620 |
Why?
|
| Learning | 2 | 2020 | 375 | 0.610 |
Why?
|
| Pneumonia | 1 | 2022 | 343 | 0.600 |
Why?
|
| Point-of-Care Testing | 1 | 2019 | 33 | 0.600 |
Why?
|
| Low Back Pain | 1 | 2019 | 40 | 0.600 |
Why?
|
| Bacteremia | 1 | 2022 | 429 | 0.580 |
Why?
|
| Weight Loss | 1 | 2022 | 518 | 0.560 |
Why?
|
| Hypoxia | 1 | 2019 | 268 | 0.560 |
Why?
|
| Muscular Diseases | 1 | 2018 | 116 | 0.550 |
Why?
|
| Capillary Fragility | 1 | 2017 | 2 | 0.540 |
Why?
|
| Bile Ducts, Intrahepatic | 1 | 2017 | 105 | 0.510 |
Why?
|
| Osteomyelitis | 1 | 2019 | 214 | 0.500 |
Why?
|
| Oxygen | 1 | 2019 | 580 | 0.490 |
Why?
|
| Bile Duct Neoplasms | 1 | 2017 | 121 | 0.480 |
Why?
|
| Cholangiocarcinoma | 1 | 2017 | 121 | 0.480 |
Why?
|
| Internship and Residency | 6 | 2024 | 1255 | 0.470 |
Why?
|
| Zika Virus Infection | 1 | 2017 | 175 | 0.450 |
Why?
|
| Clinical Competence | 3 | 2024 | 1068 | 0.420 |
Why?
|
| Teaching | 3 | 2024 | 200 | 0.420 |
Why?
|
| Students, Medical | 3 | 2024 | 363 | 0.390 |
Why?
|
| Anterior Wall Myocardial Infarction | 1 | 2012 | 11 | 0.370 |
Why?
|
| Leukemia, Promyelocytic, Acute | 1 | 2012 | 23 | 0.370 |
Why?
|
| Thrombosis | 1 | 2017 | 547 | 0.370 |
Why?
|
| Coronary Thrombosis | 1 | 2012 | 36 | 0.370 |
Why?
|
| Drug-Eluting Stents | 1 | 2012 | 70 | 0.350 |
Why?
|
| Angioplasty, Balloon, Coronary | 1 | 2012 | 184 | 0.340 |
Why?
|
| Hypertension | 1 | 2019 | 1409 | 0.340 |
Why?
|
| Humans | 22 | 2024 | 134223 | 0.290 |
Why?
|
| Education, Medical | 2 | 2022 | 304 | 0.270 |
Why?
|
| Diagnosis, Differential | 2 | 2022 | 1982 | 0.240 |
Why?
|
| Internal Medicine | 2 | 2016 | 159 | 0.220 |
Why?
|
| Congresses as Topic | 1 | 2024 | 191 | 0.200 |
Why?
|
| Leukostasis | 1 | 2022 | 1 | 0.190 |
Why?
|
| Education, Medical, Undergraduate | 1 | 2024 | 158 | 0.190 |
Why?
|
| Hospitalists | 1 | 2022 | 46 | 0.190 |
Why?
|
| Male | 7 | 2024 | 66216 | 0.180 |
Why?
|
| Curriculum | 2 | 2024 | 768 | 0.180 |
Why?
|
| Teaching Rounds | 1 | 2021 | 30 | 0.180 |
Why?
|
| Klebsiella pneumoniae | 1 | 2021 | 88 | 0.170 |
Why?
|
| Aspartate Aminotransferases | 1 | 2018 | 86 | 0.150 |
Why?
|
| Lumbar Vertebrae | 1 | 2019 | 114 | 0.140 |
Why?
|
| Communicable Diseases, Imported | 1 | 2017 | 6 | 0.130 |
Why?
|
| Aged | 3 | 2020 | 21822 | 0.130 |
Why?
|
| Blood Pressure Determination | 1 | 2017 | 116 | 0.130 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2022 | 572 | 0.120 |
Why?
|
| Arteries | 1 | 2017 | 231 | 0.120 |
Why?
|
| Liver | 1 | 2022 | 1876 | 0.110 |
Why?
|
| Middle Aged | 3 | 2022 | 29431 | 0.110 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2021 | 2204 | 0.100 |
Why?
|
| Aged, 80 and over | 1 | 2024 | 7244 | 0.100 |
Why?
|
| Bone Marrow Examination | 1 | 2012 | 14 | 0.090 |
Why?
|
| Primary Health Care | 1 | 2018 | 808 | 0.090 |
Why?
|
| Reproducibility of Results | 1 | 2019 | 3057 | 0.090 |
Why?
|
| Time Factors | 1 | 2020 | 6595 | 0.080 |
Why?
|
| Platelet Aggregation Inhibitors | 1 | 2012 | 292 | 0.080 |
Why?
|
| Anti-Bacterial Agents | 1 | 2021 | 2592 | 0.080 |
Why?
|
| Coronary Angiography | 1 | 2012 | 485 | 0.080 |
Why?
|
| Prosthesis Design | 1 | 2012 | 664 | 0.080 |
Why?
|
| Drug Therapy, Combination | 1 | 2012 | 1183 | 0.070 |
Why?
|
| Biopsy | 1 | 2012 | 1303 | 0.070 |
Why?
|
| Recurrence | 1 | 2012 | 1470 | 0.070 |
Why?
|
| Educational Measurement | 2 | 2024 | 333 | 0.070 |
Why?
|
| Adult | 2 | 2019 | 31963 | 0.070 |
Why?
|
| Education | 1 | 2024 | 111 | 0.050 |
Why?
|
| Surveys and Questionnaires | 3 | 2021 | 4008 | 0.050 |
Why?
|
| Leukapheresis | 1 | 2022 | 14 | 0.050 |
Why?
|
| Leukocytosis | 1 | 2022 | 48 | 0.050 |
Why?
|
| Hydroxyurea | 1 | 2022 | 87 | 0.040 |
Why?
|
| Female | 2 | 2019 | 72055 | 0.040 |
Why?
|
| Animals | 1 | 2022 | 36524 | 0.040 |
Why?
|
| Schools, Medical | 1 | 2020 | 124 | 0.040 |
Why?
|
| Chronic Disease | 1 | 2022 | 1251 | 0.030 |
Why?
|
| Massachusetts | 1 | 2016 | 131 | 0.030 |
Why?
|
| Evaluation Studies as Topic | 1 | 2016 | 260 | 0.030 |
Why?
|
| Pandemics | 1 | 2021 | 1193 | 0.030 |
Why?
|